Sponsor:
Parabilis Medicines, Inc.
Code:
NCT05919264
Conditions
Cancer
Colorectal Cancer
Solid Tumor
Locally Advanced Solid Tumor
Metastatic Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FOG-001
mFOLFOX-6
Nivolumab
Trifluridine/tipiracil
Bevacizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-06. This information was provided to ClinicalTrials.gov by Parabilis Medicines, Inc. on 2025-10-24.